Medicine & Health

Researchers at the School of Medicine have identified a previously unsuspected response by mouse heart muscle cells to fasting conditions: the cells’ power generators, the mitochondria, appear to remodel and consume extra internal walls or membranes in an effort to supply energy to the rest of the cell.

H. pylori bound to stomach tissueThe bacterium that causes ulcers and contributes to stomach cancers uses a clever interaction between two genes to randomly tighten and loosen its grip on the stomach, according to a study by researchers at the School of Medicine and Umeå University in Sweden.

Two St. Louis organizations have teamed up to create the Hope Center for Neurological Disorders, a unique collaboration dedicated to basic science research on a broad spectrum of nervous system conditions. A reception to celebrate the new initiative will take place at 4 p.m. on Tuesday, Oct. 5 at the Center for Advanced Medicine.

Miniscule, carefully engineered particles can detect the very beginning stages of clogged arteries in animals, thanks in large part to research at the School of Medicine. With a new five-year, $7.3 million grant, WUSM researchers will begin to translate this breakthrough into clinical advances.

Clinical trials testing treatments for neurological disorders such as Parkinson’s disease and epilepsy soon will be conducted under one roof at the School of Medicine, adding critical mass to the neuroclinical research program and convenience for patients enrolled in clinical trials.

P. Roy Vagelos, M.D., will present a lecture titled “Evolution from Basic to Translational Research (Washington University to Merck)” at noon Monday, November 29, in Cori Auditorium at Washington University School of Medicine. Vagelos was chairman of the Department of Biological Chemistry (currently the Department of Biochemistry and Molecular Biophysics) at the School of Medicine […]

Scientists at Washington University have received a five-year, $4.7 million grant from the National Cancer Institute to explore new ways to produce, distribute and use radionuclides to detect cancers.

Pain management researchers at the School of Medicine are recruiting people who have had shingles to test the effectiveness of an investigational drug designed to reduce the severe pain that can last for months or years after a bout with the disorder.

In an effort to learn about the latest research and treatments for amytrophic lateral sclerosis (ALS) and other nervous system diseases, the widow of Hans Vonk, former music director of the St. Louis Symphony Orchestra, will tour the newly established Hope Center for Neurological Disorders at the School of Medicine on Monday, Nov. 15.

Originating in Washington University research laboratories, St. Louis-based biotechnology company Apath has generated enough profit in just seven years to contribute $1 million in royalty payments back to the School of Medicine.